Development of the new strategy targeting for the RAD51 overexpression mammary tumor
Project/Area Number |
24780313
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Clinical veterinary science
|
Research Institution | Nippon Veterinary and Life Science University |
Principal Investigator |
OCHIAI Kazuhiko 日本獣医生命科学大学, 獣医学部, 講師 (30550488)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | イヌ / 乳腺腫瘍 / BRCA2 / RAD51 / 多型 / 乳がん / DNA相同組換え / 乳癌 / 相同組換え / 分子創薬 |
Outline of Final Research Achievements |
Canine BRCA2 and RAD51 genes locus has been associated with mammary tumors in female dogs. The BRCA2 protein is involved in homologous recombination repair via its interaction with RAD51 recombinase, an interaction mediated by 8 BRC repeats. Previous structural analyses of cancer-associated mutations affecting the BRC repeats have shown that the weakening of RAD51’s affinity for even 1 repeat is sufficient to increase breast cancer susceptibility. In this study, we focused on 2 previously reported canine BRCA2 mutations (T1425P and K1435R) in BRC repeat 3 (BRC3), derived from mammary tumor samples. These mutations affected the interaction of canine BRC3 with RAD51, and were considered deleterious. Two BRC3 mutations (K1440R and K1440E), reported in human breast cancer patients, occur at amino acids corresponding to those of the K1435R mutation in dogs.
|
Report
(4 results)
Research Products
(20 results)
-
[Journal Article] Polymorphisms of canine BRCA2 BRC repeats affecting interaction with RAD51.2015
Author(s)
Ochiai, K., Ishiguro-Oonuma, T., Yoshikawa, Y., Udagawa, C., Kato, Y., Watanabe, M., Bonkobara, M., Morimatsu, M., and Omi, T.
-
Journal Title
Biomed. Res.
Volume: in press
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector2014
Author(s)
Watanabe M., Sakaguchi M., Kinoshita R., Kaku H., Ariyoshi Y., Ueki H., Tanimoto R., Ebara S., Ochiai K., Futami J., Li SA., Huang P., Nasu Y., Huh NH., Kumon H
-
Journal Title
Oncology Reports
Volume: 31巻
Issue: 3
Pages: 1089-95
DOI
Related Report
Peer Reviewed
-
[Journal Article] Concentration of Radiocesium in the Wild Japanese Monkey (Macaca fuscata) over the First 15 Months after the Fukushima Daiichi Nuclear Disaster.2013
Author(s)
Hayama, S., Nakiri, S., Nakanishi, S., Ishii, N., Uno, T., Kato, T., Konno, F., Kawamoto, Y., Tsuchida, S., Ochiai, K., and Omi, T.
-
Journal Title
PLoS ONE
Volume: e68530
Issue: 7
Pages: e68530-e68530
DOI
Related Report
Peer Reviewed
-
[Journal Article] Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours2013
Author(s)
Ochiai, K., Watanabe, M., Azakami, D., Michishita, M., Yoshikawa, Y., Udagawa, C., Metheenukul, P., Chahomchuen, T., Aoki, H., Kumon, H., Morimatsu, M., Omi, T.
-
Journal Title
Vet. J
Volume: 197(3)
Issue: 3
Pages: 769-775
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Preclinical Safety and Efficacy of in Situ REIC/Dkk-3 Gene Therapy for Prostate Cancer.2012
Author(s)
Kawauchi, K., Watanabe, M., Kaku, H., Huang, P., Sasaki, K., Sakaguchi, M., Ochiai, K., Huh, NH., Nasu, Y., and Kumon, H.
-
Journal Title
Acta Med. Okayama
Volume: 66
Pages: 7-16
Related Report
Peer Reviewed
-
[Journal Article] Establishment of a PCR analysis method for canine BRCA22012
Author(s)
Yoshikawa Y, Morimatsu M, Ochiai K, Okuda K, Taoda T, Chikazawa S, Shimamura A, Omi T, Bonkobara M, Orino K, Watanabe K.
-
Journal Title
BMC Res Notes
Volume: (in press)
Issue: 1
Pages: 173-173
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-